ZMD Zoommed Inc

ZoomMed Inc. (TSX VENTURE:ZMD), announces that it has completed its private
placement announced on February 3, 2011 (the "Private Placement"), with the
closing of a second tranche for gross proceeds of $507,999 subscribed by Le
Fonds d'Investissement REA II Natcan Inc. The aggregate size of the two Private
Placement closings is $2,500,599. As part of this second closing, 3,277,419
units of ZoomMed were issued at a price of $0.155 per unit ("Unit").
Accordingly, the aggregate Units sold under the Private Placement is 16,132,902
Units. Each Unit consists of one common share of ZoomMed Inc. ("Common Share")
and one-half warrant. Each whole warrant entitles the holder thereof to purchase
one Common Share at an exercise price of $0.17 for a period of 24 months from
the date of the closing of the financing. The Common Shares and warrants are
subject to a mandatory hold period of 4 months and 1 day from the date of the
closing.


Avenue Capital Markets CPVC Inc., a Montreal-based Exempt Market Dealer, acted
as agent for the Private Placement and received a cash fee equivalent to 8% of
the gross proceed of the Private Placement and an agent's option to purchase a
number of Units, under the same terms and conditions as Units of the Private
Placement, equivalent to 8% of the total number of Units sold.


The uses of proceeds of the Private Placement include the acquisition of Praxis
Sante Inc. and additional working capital for ZoomMed Inc. 


ZoomMed has received an advance income tax ruling from the "Ministere du Revenu
du Quebec" confirming that ZoomMed qualifies as a "qualified issuing
corporation" and that the shares issued in regards of the Private Placement
qualifies as "qualifying shares" for inclusion in a "Quebec Stock Savings Plan
II".


The Private Placement is subject to the final approval of the TSX Venture
Exchange and other regulatory authorities.


About ZoomMed 

ZoomMed's developed the ZRx Prescriber, a technological innovative Web
application that enables physicians to use a wireless device, such as the IPod
Touch(TM), IPhone(TM), IPad(TM), Google Android(TM), other PDA's or computers,
to write and rapidly deliver scripts. The ZRx Prescriber is quick, efficient and
intuitive. Since it is a stand-alone product, it can easily be integrated to any
Electronic Medical Record application (EMR).


For further information on ZoomMed visit our Web Site; www.zoommed.com. 

About Avenue Capital Market 

Avenue Capital Markets CPVC Inc. is an independent exempt market dealer
dedicated to supporting the growth of small to mid cap companies located
primarily in Quebec. Avenue provides dynamic entrepreneurs with access to
capital markets, corporate advisory services and experienced mentor networks.


For further information about Avenue Capital Market, please visit the Web Site;
www.avenuecapitalmarkets.com

Zoommed (TSXV:ZMD)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Zoommed (TSXV:ZMD)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024